General Information
Revision date
2021-01-27
Product name
Droxidopa Capsules
Product Synonyms
Droxidopa Capsules, 100, 200 and 300 mg
Chemical name
(-)-threo-3-(3,4-Dihydroxyphenyl)-L-serine
CAS No.
23651-95-8
1.2.1 Relevant identified uses
NORTHERA is indicated for the treatment of orthostatic dizziness, lightheadedness, or the “feeling that you are about to black out”
Manufacturer Name
ScieGen Pharmaceuticals, Inc
Icons in SDS
Company Information
company name
ScieGen Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
Additional Hazard Dust may cause irritation (based on components). The active Information: Short Term: ingredient is not acutely toxic. Adverse effects associated with therapeutic use include Known Clinical Effects: dizziness, tiredness, swelling, and nausea. Non-hazardous in accordance with international standards for
Hazard statements
workplace safety.
EU Classification
Not classified EU Indication of danger Australian Hazard Non-Hazardous Substance. Non-Dangerous Goods.
